CHILDRENS HOSPITAL OF THE KINGS DA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 451
- Companies
- 36
- Average per transaction
- $2,606
Who reported the payments
| Biogen | $447,165 |
| Insulet Corporation | $222,025 |
| Jazz Pharmaceuticals Inc. | $194,851 |
| Medtronic | $83,019 |
| Pfizer | $50,214 |
| Tandem Diabetes Care, Inc. | $38,700 |
| Biomarin Pharmaceutical Inc. | $20,562 |
| Novo Nordisk AS | $18,331 |
| PTC Therapeutics, Inc. | $13,410 |
| Sarepta Therapeutics, Inc. | $12,620 |
| E.r. Squibb & Sons, L.L.C. | $12,128 |
| Incyte Corporation | $12,114 |
| Stryker | $11,828 |
| Medline Industries LP | $7,130 |
| Streck LLC | $6,542 |
| National Marrow Donor Program | $5,500 |
| Medical Device Business Services, Inc. | $5,000 |
| KARL Storz Endoscopy-america | $3,510 |
| Convatec Inc. | $2,500 |
| Teva Pharmaceuticals USA, Inc. | $1,900 |
| Biofire Diagnostics, LLC | $1,549 |
| AbbVie | $1,105 |
| Luminex Corporation | $1,029 |
| Merck | $496 |
| Applied Medical Technology Inc | $400 |
| Amgen | $391 |
| Linvatec Corporation | $308 |
| Medela LLC | $250 |
| Med-el Corporation | $129 |
| Vero Biotech Inc. | $121 |
| Neurelis, Inc. | $106 |
| Regeneron | $100 |
| SPS Medical Supply Corp. | $99 |
| Olympus America Inc. | $73 |
| Boston Scientific | $50 |
| AstraZeneca | $25 |